rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Parenteral Drugs (India) Ltd. - Research Center
524689 PARENTLD Group (Z) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Profit loss account
(Rs crore)
Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19 Mar ' 18
Income
Operating income 8.50 12.17 31.87 32.03 32.95
Expenses
Material consumed 5.47 5.67 6.78 7.17 6.95
Manufacturing expenses - 1.64 15.90 17.27 14.41
Personnel expenses 14.79 14.51 19.21 19.94 16.70
Selling expenses - - 0.03 0.04 0.13
Adminstrative expenses 3.26 2.11 4.63 5.27 10.60
Expenses capitalised - - - - -
Cost of sales 23.51 23.94 46.56 49.68 48.79
Operating profit -15.01 -11.77 -14.68 -17.66 -15.84
Other recurring income 0.07 0.06 0.25 1.44 1.34
Adjusted PBDIT -14.94 -11.71 -14.43 -16.22 -14.50
Financial expenses 106.25 125.44 109.96 96.05 86.34
Depreciation 40.15 17.33 17.35 69.12 18.57
Other write offs - - - - -
Adjusted PBT -161.34 -154.47 -141.73 -181.39 -119.40
Tax charges -32.76 -32.76 -27.66 -33.49 -23.31
Adjusted PAT -128.57 -121.71 -114.07 -147.90 -96.09
Non recurring items 52.21 0.14 -0.31 -0.25 -0.02
Other non cash adjustments - - - - -
Reported net profit -76.36 -121.57 -114.38 -148.16 -96.12
Earnigs before appropriation -76.36 -1,034.97 -913.41 -799.02 -650.87
Equity dividend - - - - -
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings -76.36 -1,034.97 -913.41 -799.02 -650.87
Close
Add Parenteral Drugs (India) Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Parenteral Drugs (India) Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close